1.Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

Jiang, ZB, Wang, WJ,     More...

Jiang, ZB, Wang, WJ, Xu, C, Xie, YJ, Wang, XR, Zhang, YZ, Huang, JM, Huang, M, Xie, C, Liu, P, Fan, XX, Ma, YP, Yan, PY, Liu, L, Yao, XJ, Wu, QB, Leung, ELH     Less

CANCER LETTERS[0304-3835], Published 2021, Volume 515, Pages 36-48

收錄情况： WOS SCOPUS

WOS核心合集引用: 211  2024影響因子:  10.1  发表年影響因子:  9.756 

2.Overcoming EGFR TKI resistance and immunosuppression in non-small cell lung cancer via EGFR/TLR9/PD-L1 triple-targeted therapy

Zhang, WY, Wang, ZQ,     More...

Zhang, WY, Wang, ZQ, Fan, XX     Less

CANCER LETTERS[0304-3835], Published 2026, Volume 639,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2024影響因子:  10.1